Latest KFF Health News Stories
At Stake in Mifepristone Case: Abortion, FDA’s Authority, and Return to 1873 Obscenity Law
The end goal for a conservative Christian group’s mifepristone case before the Supreme Court: a de facto nationwide abortion ban.
Ya hay una droga oral para la depresión postparto… pero cuesta $16,000
Abogados, defensores y reguladores están observando de cerca cómo las aseguradoras diseñarán las normas para cubrirlo.
A New $16,000 Postpartum Depression Drug Is Here. How Will Insurers Handle It?
A pill form of an effective drug for postpartum depression hit the market in December, but most insurers do not yet have a policy on when or whether they will pay for it. The hurdles to obtain its predecessor medication have advocates worried.
Colorado Isn’t Giving up on Its Drug Importation Dream
Colorado hopes to join Florida to become only the second state authorized to import prescription drugs from Canada. But they’re hitting the same hurdles: drugmakers — and the FDA. Colorado officials recently amended their 2022 importation application with the Food and Drug Administration, in the process revealing new correspondence that shows the state’s so-far fruitless […]
Toxic Gas That Sterilizes Medical Devices Prompts Safety Rule Update
The Environmental Protection Agency is tightening regulation of ethylene oxide, a carcinogenic gas used to sterilize medical devices. The agency is trying to balance the interests of the health care industry supply chain with those of communities where the gas creates airborne health risks.
Washington intenta ponerse al día con el uso de la inteligencia artificial en el sector de salud
El impacto de la IA en el sector de salud ya es generalizado. La Administración de Alimentos y Medicamentos ha aprobado unos 692 productos de inteligencia artificial.
‘Behind the Times’: Washington Tries to Catch Up With AI’s Use in Health Care
Lawmakers and regulators are trying to understand how AI is changing health care and how it should be regulated. The industry fears overreach.
La FDA finalmente prohibiría peligroso químico en productos para alisar el cabello
El primer estudio que vinculó los alisadores de cabello con el cáncer de útero, publicado en 2022, encontró que el uso frecuente de estos químicos duplica con creces el peligro.
FDA’s Plan to Ban Hair Relaxer Chemical Called Too Little, Too Late
The FDA’s recent notice that it would move to ban formaldehyde in hair-straightening products comes more than a decade after researchers raised alarms about health risks. Scientists say a ban would still leave many dangerous chemicals in hair straighteners.
Ketamine Therapy for Mental Health a ‘Wild West’ for Doctors and Patients
Ketamine, approved by the FDA as an anesthetic in 1970, is emerging as a major alternative mental health treatment, and there are now more than 500 ketamine clinics around the country. But with little regulation and widely varying treatment protocols, it’s a medical “wild West.”
Journalists Track Medical Device Malfunctions, Opioid Settlement Payments, and Abortion Bans
KFF Health News and California Healthline staffers made the rounds on national and local media this week to discuss their stories. Here’s a collection of their appearances.
Pacientes con narcolepsia enfrentan una doble pesadilla: escasez de medicamentos y estigma
Se estima que una de cada 2,000 personas en los Estados Unidos vive con narcolepsia (más de 160,000 en todo el país).
Patients With Narcolepsy Face a Dual Nightmare of Medication Shortages and Stigma
It’s been more than a year since the FDA declared a national shortage of Adderall, and it’s affecting more than just patients with ADHD. Those with narcolepsy, a much rarer condition, are often treated with the same medication. Without it, they’re often unable to drive or function as usual.
‘AGGA’ Inventor Testifies His Dental Device Was Not Meant for TMJ or Sleep Apnea
The FDA and Department of Justice are investigating the Anterior Growth Guidance Appliance, or “AGGA.” TMJ and sleep apnea patients have filed lawsuits alleging the device harmed them. Its inventor now says the AGGA was never meant for these ailments.
Deep Flaws in FDA Oversight of Medical Devices, and Patient Harm, Exposed in Lawsuits and Records
Thousands of medical devices are sold, and even implanted, with no safety tests.
Patients Facing Death Are Opting for a Lifesaving Heart Device — But at What Risk?
The HeartMate 3 is considered the safest mechanical heart pump of its kind, but a federal database contains more than 4,500 reports in which the medical device may have caused or contributed to a patient’s death.
Hongos misteriosos son el centro de brote de intoxicación alimentaria
Según el Código Alimentario de la FDA, la gran mayoría de las más de 5,000 especies de hongos carnosos que crecen naturalmente en América del Norte no han sido sometidas a pruebas de toxicidad.
Mysterious Morel Mushrooms at Center of Food Poisoning Outbreak
Federal officials issued their first guidelines on preparing morel mushrooms after a deadly food poisoning outbreak in Montana, noting the toxins in the delicacy aren’t fully understood.
KFF Health News' 'What the Health?': Democrats See Opportunity in GOP Threats to Repeal Health Law
Sensing that Republicans are walking into a political minefield by threatening once again to repeal the Affordable Care Act, the Biden administration is looking to capitalize by rolling out a series of initiatives aimed at high drug prices and other consequences of “corporate greed in health care.” Meanwhile, the Supreme Court hears a case that could determine when and how much victims of the opioid crisis can collect from Purdue Pharma, the drug company that lied about how addictive its drug, OxyContin, really was. Alice Miranda Ollstein of Politico, Anna Edney of Bloomberg News, and Rachana Pradhan of KFF Health News join KFF Health News chief Washington correspondent Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Dan Weissmann of KFF Health News’ sister podcast, “An Arm and a Leg,” about his investigation into hospitals suing their patients over unpaid bills.
KFF Health News' 'What the Health?': Trump Puts Obamacare Repeal Back on Agenda
Although Republicans have never united behind a replacement for the Affordable Care Act, 2024 GOP presidential front-runner Donald Trump said this week he wants to put the issue back on the national agenda. That delights Democrats, who have won at least two elections partly by defending the now-popular health law. Meanwhile, the Texas Supreme Court takes up a case brought by women who say their pregnancy complications further endangered their health due to the vagueness of Texas’ near-total ban on abortions. Joanne Kenen of Johns Hopkins University and Politico Magazine, Sarah Karlin-Smith of the Pink Sheet, and Victoria Knight of Axios News join KFF Health News chief Washington correspondent Julie Rovner to discuss these issues and more. Also this week, Rovner interviews KFF Health News’ Rachana Pradhan, who reported and wrote the latest “Bill of the Month” feature.
